Assessment of the association between glycemic variability and diabetes-related complications in type 1 and type 2 diabetes

被引:172
|
作者
Smith-Palmer, J. [1 ]
Braendle, M. [2 ]
Trevisan, R. [3 ]
Federici, M. Orsini [4 ]
Liabat, S. [5 ]
Valentine, W. [1 ]
机构
[1] Ossian Hlth Econ & Commun, CH-4051 Basel, Switzerland
[2] Kantonsspital St Gallen, St Gallen, Switzerland
[3] Osped Riuniti Bergamo, I-24100 Bergamo, Italy
[4] SpA, Medtron Italia, Milan, Italy
[5] Medtron Int Trading Sarl, Tolochenaz, Switzerland
关键词
Glycemic variability; Microvascular complications; Macrovascular complications; FASTING PLASMA-GLUCOSE; CORONARY-ARTERY-DISEASE; MEAN BLOOD-GLUCOSE; HBA(1C) VARIABILITY; MICROVASCULAR COMPLICATIONS; CARDIOVASCULAR-DISEASE; RISK-FACTOR; INDEPENDENT CORRELATE; CHRONIC HYPERGLYCEMIA; RENAL-INSUFFICIENCY;
D O I
10.1016/j.diabres.2014.06.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic hyperglycemia is the main risk factor for the development of diabetes-related complications in both type 1 and type 2 diabetes, but it is thought that frequent or large glucose fluctuations may contribute independently to diabetes-related complications. A systematic literature review was performed using the PubMed, EMBASE and Cochrane Library databases with searches limited to studies published from June 2002 to March 2014, in English and including >= 50 patients. Twenty eight articles were included in the final review. Eighteen studies reported the association between glucose variability and diabetes-related complications exclusively in type 2 diabetes. A positive association between increased variability and microvascular complications and coronary artery disease was consistently reported. Associations between glucose variability and other macrovascular complications were inconsistent in type 2 diabetes. Seven studies examined the association between glucose variability and complications exclusively in type 1 diabetes. Increased glucose variability appears to play a minimal role in the development of micro- and macrovascular complications in type 1 diabetes. Consistent findings suggest that in type 2 diabetes glucose variability is associated with development of microvascular complications. The role of increased glucose variability in terms of microvascular and macrovascular complications in type 1 diabetes is less clear; more data in are needed. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:273 / 284
页数:12
相关论文
共 50 条
  • [31] Glycemic variability in the development of cardiovascular complications in diabetes
    Nusca, Annunziata
    Tuccinardi, Dario
    Albano, Marzia
    Cavallaro, Camilla
    Ricottini, Elisabetta
    Manfrini, Silvia
    Pozzilli, Paolo
    Di Sciascio, Germano
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2018, 34 (08)
  • [32] Estimation of the impact of diabetes-related complications on health utilities for patients with type 2 diabetes in Ontario, Canada
    O'Reilly, Daria J.
    Xie, Feng
    Pullenayegum, Eleanor
    Gerstein, Hertzel C.
    Greb, Janet
    Blackhouse, Gord K.
    Tarride, Jean-Eric
    Bowen, Jim
    Goeree, Ron A.
    QUALITY OF LIFE RESEARCH, 2011, 20 (06) : 939 - 943
  • [33] Long-term Fasting Glycemic Variability and Microvascular Complications in Type 2 Diabetes
    Wander, Pandora L.
    Boyko, Edward J.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (07) : E2822 - E2824
  • [34] Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes
    Su, Gong
    Mi, Shuhua
    Tao, Hong
    Li, Zhao
    Yang, Hongxia
    Zheng, Hong
    Zhou, Yun
    Ma, Changsheng
    CARDIOVASCULAR DIABETOLOGY, 2011, 10
  • [35] Association between glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with cardiovascular complications
    Huri, Hasniza Zaman
    Ling, Doris Yew Hui
    Ahmed, Wan Azman Wan
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 4735 - 4749
  • [36] Short-term Glycemic Variability and Its Association With Macrovascular and Microvascular Complications in Patients With Diabetes
    Psoma, Ourania
    Makris, Marios
    Tselepis, Alexandros
    Tsimihodimos, Vasilis
    JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2024, 18 (04): : 956 - 967
  • [37] Co-occurrence of early diabetes-related complications in adolescents and young adults with type 1 diabetes: an observational cohort study
    Sauder, Katherine A.
    Stafford, Jeanette M.
    Mayer-Davis, Elizabeth J.
    Jensen, Elizabeth T.
    Saydah, Sharon
    Mottl, Amy
    Dolan, Lawrence M.
    Hamman, Richard F.
    Lawrence, Jean M.
    Pihoker, Catherine
    Marcovina, Santica
    D'Agostino, Ralph B., Jr.
    Dabelea, Dana
    LANCET CHILD & ADOLESCENT HEALTH, 2019, 3 (01) : 35 - 43
  • [38] Adult Stature and Diabetes Complications in Patients With Type 1 Diabetes The FinnDiane Study and the Diabetes Control and Complications Trial
    Waden, Johan
    Forsblom, Carol
    Thorn, Lena M.
    Saraheimo, Markku
    Rosengard-Barlund, Milla
    Heikkila, Outi
    Hietala, Kustaa
    Ong, Ken
    Wareham, Nicholas
    Groop, Per-Henrik
    DIABETES, 2009, 58 (08) : 1914 - 1920
  • [39] Long-Term Glycemic Variability and Vascular Complications in Type 2 Diabetes: Post Hoc Analysis of the FIELD Study
    Scott, Emma S.
    Januszewski, Andrzej S.
    O'Connell, Rachel
    Fulcher, Gregory
    Scott, Russell
    Kesaniemi, Antero
    Wu, Linda
    Colagiuri, Stephen
    Keech, Anthony
    Jenkins, Alicia J.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (10)
  • [40] Endothelial Progenitor Cells Are Related to Glycemic Control in Children With Type 1 Diabetes Over Time
    Hoertenhuber, Thomas
    Rami-Mehar, Birgit
    Sailer, Miriam
    Nagl, Katrin
    Hoebaus, Clemens
    Hollerl, Florian
    Koppensteiner, Renate
    Schernthaner, Guntram
    Schober, Edith
    Schernthaner, Gerit-Holger
    DIABETES CARE, 2013, 36 (06) : 1647 - 1653